#ACR26 Day Four is in the books ✅
In the Exhibit Hall this afternoon, we asked our attendees about the most interesting thing they learned today. Their different perspectives perfectly reflected the diversity of the #rheum community!
What was the most interesting thing you learned today? Let us know in the comments!
#Rheumatology #PediatricRheumatology #ACRConvergence
The best part about IM is that it encompasses anything and everything. Had the privilege to present a case I saw as an intern at ACP MO!
#MedTwitter#internalmedicine
Baby steps into rheumatology, guided by the incredible @KilianMD .
@CCRheum was a masterclass—with invaluable one-on-one feedback from the best in the field during poster rounds!
As the rare diseases day approaches on Feb 28th, the February issue issue of DADA2 foundation newsletter puts spotlight on our Indian Cohort. Which perhaps is largest in the world. Still a lot needs to be done in this field.
Happy to share that Indian Rheumatology Association guidelines for the management of ANCA ... o mine now. Would be especially helpful in decision making in resource constrained settings https://t.co/PkuXvPjUKZ
Humbled and honored to see my name among such esteemed contributors in the field. Immense gratitude to my mentor, one of the best, Dr. Aman Sharma, for his guidance and this incredible opportunity at such an early stage of my training!
@Amansharmapgi#MedTwitter
GLP 1 agonists and SGLT2 inhibitors are having quite the year. At this rate a combination would act as a panacea. Too bad one is an injectable.
#MedX#MedTwitter
A Brief History of Rheumatoid Arthritis Mimics
Imagine that 100 years from now, your great granddaughter, an eminent rheumatologist, reviews the history of rheumatoid arthritis (#RA) mimics.
https://t.co/Jv4Mdha7Kq
The ACR & @eular_org have developed new antiphospholipid syndrome (APS) classification criteria, providing a strong foundation for future #APS research. View → https://t.co/a0FXd310BT